Catalyst Wire Dossier Catalyst Wire Dossier

Umeclidinium/Vilanterol

umeclidinium/vilanterol · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Umeclidinium/Vilanterol, covering 2014-02-11 to 2024-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure [Phase 4]

See pricing